(19)
(11) EP 4 392 058 A1

(12)

(43) Date of publication:
03.07.2024 Bulletin 2024/27

(21) Application number: 22768761.3

(22) Date of filing: 23.08.2022
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
C07K 14/725(2006.01)
 A61P 35/00(2006.01)
C07K 14/705(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 2039/876; A61P 35/00; C07K 14/7051; C07K 14/70578; C07K 14/70521; C07K 2319/03; A61K 2239/57; A61K 39/464489; A61K 39/46449; A61K 2239/38; A61K 39/4611; A61K 39/4632; A61K 39/464411; A61K 39/464488
(86) International application number:
PCT/EP2022/073443
(87) International publication number:
WO 2023/025779 (02.03.2023 Gazette 2023/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.08.2021 EP 21192987

(71) Applicant: Medigene Immunotherapies GmbH
82152 Planegg-Martinsried (DE)

(72) Inventors:
  • BÜRDEK, Maja
    81669 München (DE)
  • MUTZE, Kathrin
    80637 München (DE)
  • PRINZ, Petra
    82205 Gilching (DE)
  • HELMBRECHT, Angelika
    85646 Neufarn (DE)

(74) Representative: Maiwald GmbH 
Elisenhof Elisenstraße 3
80335 München
80335 München (DE)

   


(54) COMBINATION OF ANTIGEN SPECIFIC T CELL RECEPTORS AND CHIMERIC CO-STIMULATORY RECEPTORS